217 related articles for article (PubMed ID: 16759681)
1. North and South American Loxosceles spiders: development of a polyvalent antivenom with recombinant sphingomyelinases D as antigens.
Olvera A; Ramos-Cerrillo B; Estévez J; Clement H; de Roodt A; Paniagua-Solís J; Vázquez H; Zavaleta A; Arruz MS; Stock RP; Alagón A
Toxicon; 2006 Jul; 48(1):64-74. PubMed ID: 16759681
[TBL] [Abstract][Full Text] [Related]
2. Toxicity of two North American Loxosceles (brown recluse spiders) venoms and their neutralization by antivenoms.
de Roodt AR; Estevez-Ramírez J; Litwin S; Magaña P; Olvera A; Alagón A
Clin Toxicol (Phila); 2007 Sep; 45(6):678-87. PubMed ID: 17849243
[TBL] [Abstract][Full Text] [Related]
3. A reduced immunization scheme to obtain an experimental anti-Loxosceles laeta ("violinist spider") venom.
de Roodt AR; Litwin S; Dokmetjian JC; Vidal JC
J Nat Toxins; 2002 Aug; 11(3):193-203. PubMed ID: 12182539
[TBL] [Abstract][Full Text] [Related]
4. Enzymatic characterization, antigenic cross-reactivity and neutralization of dermonecrotic activity of five Loxosceles spider venoms of medical importance in the Americas.
Barbaro KC; Knysak I; Martins R; Hogan C; Winkel K
Toxicon; 2005 Mar; 45(4):489-99. PubMed ID: 15733571
[TBL] [Abstract][Full Text] [Related]
5. A new anti-loxoscelic serum produced against recombinant sphingomyelinase D: results of preclinical trials.
de Almeida DM; Fernandes-Pedrosa Mde F; de Andrade RM; Marcelino JR; Gondo-Higashi H; de Azevedo Ide L; Ho PL; van den Berg C; Tambourgi DV
Am J Trop Med Hyg; 2008 Sep; 79(3):463-70. PubMed ID: 18784245
[TBL] [Abstract][Full Text] [Related]
6. Genetic and enzymatic characterization of sphingomyelinase D isoforms from the North American fiddleback spiders Loxosceles boneti and Loxosceles reclusa.
Ramos-Cerrillo B; Olvera A; Odell GV; Zamudio F; Paniagua-Solís J; Alagón A; Stock RP
Toxicon; 2004 Oct; 44(5):507-14. PubMed ID: 15450925
[TBL] [Abstract][Full Text] [Related]
7. Molecular cloning and functional characterization of two isoforms of dermonecrotic toxin from Loxosceles intermedia (brown spider) venom gland.
da Silveira RB; Pigozzo RB; Chaim OM; Appel MH; Dreyfuss JL; Toma L; Mangili OC; Gremski W; Dietrich CP; Nader HB; Veiga SS
Biochimie; 2006 Sep; 88(9):1241-53. PubMed ID: 16581177
[TBL] [Abstract][Full Text] [Related]
8. Molecular cloning, expression, function and immunoreactivities of members of a gene family of sphingomyelinases from Loxosceles venom glands.
Tambourgi DV; de F Fernandes Pedrosa M; van den Berg CW; Gonçalves-de-Andrade RM; Ferracini M; Paixão-Cavalcante D; Morgan BP; Rushmere NK
Mol Immunol; 2004 Jul; 41(8):831-40. PubMed ID: 15234562
[TBL] [Abstract][Full Text] [Related]
9. Generation and molecular characterization of a monoclonal antibody reactive with conserved epitope in sphingomyelinases D from Loxosceles spider venoms.
Dias-Lopes C; Felicori L; Rubrecht L; Cobo S; Molina L; Nguyen C; Galéa P; Granier C; Molina F; Chávez-Olortegui C
Vaccine; 2014 Apr; 32(18):2086-92. PubMed ID: 24565754
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous loxoscelism caused by Loxosceles similis venom and neutralization capacity of its specific antivenom.
Chatzaki M; Horta CC; Almeida MO; Pereira NB; Mendes TM; Dias-Lopes C; Guimarães G; Moro L; Chávez-Olórtegui C; Horta MC; Kalapothakis E
Toxicon; 2012 Jul; 60(1):21-30. PubMed ID: 22465492
[TBL] [Abstract][Full Text] [Related]
11. Innovative immunization protocols using chimeric recombinant protein for the production of polyspecific loxoscelic antivenom in horses.
Figueiredo LF; Dias-Lopes C; Alvarenga LM; Mendes TM; Machado-de-Ávila RA; McCormack J; Minozzo JC; Kalapothakis E; Chávez-Olórtegui C
Toxicon; 2014 Aug; 86():59-67. PubMed ID: 24878371
[TBL] [Abstract][Full Text] [Related]
12. Anti-loxoscelic horse serum produced against a recombinant dermonecrotic protein of Brazilian Loxosceles intermedia spider neutralize lethal effects of Loxosceles laeta venom from Peru.
Duarte CG; Bonilla C; Guimarães G; Machado de Avila RA; Mendes TM; Silva W; Tintaya B; Yarleque A; Chávez-Olórtegui C
Toxicon; 2015 Jan; 93():37-40. PubMed ID: 25448393
[TBL] [Abstract][Full Text] [Related]
13. Functional characterization and epitope analysis of a recombinant dermonecrotic protein from Loxosceles intermedia spider.
Felicori L; Araujo SC; de Avila RA; Sanchez EF; Granier C; Kalapothakis E; Chávez-Olórtegui C
Toxicon; 2006 Oct; 48(5):509-19. PubMed ID: 16934304
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics in rabbits and anti-sphingomyelinase D neutralizing power of Fab, F(ab')(2), IgG and IgG(T) fragments from hyper immune equine plasma.
Vázquez H; Olvera F; Paniagua-Solís J; Alagón A; Sevcik C
Int Immunopharmacol; 2010 Apr; 10(4):447-54. PubMed ID: 20093203
[TBL] [Abstract][Full Text] [Related]
15. Biochemical and immunological characteristics of Peruvian Loxosceles laeta spider venom: neutralization of its toxic effects by anti-loxoscelic antivenoms.
Guimarães G; Dias-Lopes C; Duarte CG; Felicori L; Machado de Avila RA; Figueiredo LF; de Moura J; Faleiro BT; Barro J; Flores K; Silva W; Tintaya B; Yarleque A; Bonilla C; Kalapothakis E; Salas CE; Chávez-Olortegui C
Toxicon; 2013 Aug; 70():90-7. PubMed ID: 23648420
[TBL] [Abstract][Full Text] [Related]
16. Protection against dermonecrotic and lethal activities of Loxosceles intermedia spider venom by immunization with a fused recombinant protein.
Araujo SC; Castanheira P; Alvarenga LM; Mangili OC; Kalapothakis E; Chávez-Olórtegui C
Toxicon; 2003 Mar; 41(3):261-7. PubMed ID: 12565747
[TBL] [Abstract][Full Text] [Related]
17. Recombinant Protein Containing B-Cell Epitopes of Different
Lima SA; Guerra-Duarte C; Costal-Oliveira F; Mendes TM; Figueiredo LFM; Oliveira D; Machado de Avila RA; Ferrer VP; Trevisan-Silva D; Veiga SS; Minozzo JC; Kalapothakis E; Chávez-Olórtegui C
Front Immunol; 2018; 9():653. PubMed ID: 29666624
[TBL] [Abstract][Full Text] [Related]
18. An in vivo protective response against toxic effects of the dermonecrotic protein from Loxosceles intermedia spider venom elicited by synthetic epitopes.
Felicori L; Fernandes PB; Giusta MS; Duarte CG; Kalapothakis E; Nguyen C; Molina F; Granier C; Chávez-Olórtegui C
Vaccine; 2009 Jun; 27(31):4201-8. PubMed ID: 19389441
[TBL] [Abstract][Full Text] [Related]
19. A novel ICK peptide from the Loxosceles intermedia (brown spider) venom gland: cloning, heterologous expression and immunological cross-reactivity approaches.
Matsubara FH; Gremski LH; Meissner GO; Constantino Lopes ES; Gremski W; Senff-Ribeiro A; Chaim OM; Veiga SS
Toxicon; 2013 Sep; 71():147-58. PubMed ID: 23751278
[TBL] [Abstract][Full Text] [Related]
20. Synthetic peptides for in vitro evaluation of the neutralizing potency of Loxosceles antivenoms.
Ramada JS; Becker-Finco A; Minozzo JC; Felicori LF; Machado de Avila RA; Molina F; Nguyen C; de Moura J; Chávez-Olórtegui C; Alvarenga LM
Toxicon; 2013 Oct; 73():47-55. PubMed ID: 23856101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
